The first AI research agent fine-tuned on rare disease literature, omics, and regulatory data. Covers literature intelligence, omics interpretation, experimental design, and regulatory strategy — all in one.
Synthesize PubMed across rare disease indications. Identify mechanism gaps, preclinical evidence, and clinical precedents instantly.
Interpret RNA-seq, differential expression, and pathway analysis in the context of rare disease biology — not generic oncology.
Design cell-based assays, animal model protocols, and DRUG-seq workflows optimized for rare genetic diseases.
Map 505(b)(2), ODD, NCIE, and pediatric extension pathways. Draft pre-IND meeting briefs and regulatory memos.
Evaluate drug candidates against disease transcriptomic signatures. Understand mechanism plausibility and clinical translatability.
Query ClinicalTrials.gov, ChEMBL, and patent databases in natural language. Get structured competitive intelligence, not raw data.
Your pipeline data. Your model. We fine-tune ORPharma on your proprietary datasets — clinical data, protocols, internal research — and deliver a dedicated model your team owns.
Designed for university rare disease research labs. NRF grant-eligible (소프트웨어 구입비). On-premise deployment for IRB data security compliance.
✓ NRF 연구비 집행 가능ORPharma is in active development. Early access teams help shape the product — and get priority onboarding.